Skip to main content
. Author manuscript; available in PMC: 2013 Nov 20.
Published in final edited form as: J Nucl Med. 2012 Feb 6;53(3):10.2967/jnumed.111.097162. doi: 10.2967/jnumed.111.097162

FIGURE 4.

FIGURE 4

Comparison of total VT in various brain regions. VT values were calculated in 7 subjects injected with 11C-NOP-1A using unconstrained 2-tissue-compartment model for VOI data and Logan and MA1 methods for voxel data (Loganvoxel and MA1voxel). (A) Mean VT values obtained by both MA1voxel (hatched bars) and Loganvoxel (white bars) were significantly lower than those obtained by 2-tissue-compartment model (black bars) (P < 0.05 by factorial repeated-measures ANOVA). Loganvoxel gave significantly smaller VT values than MA1voxel (P < 0.05). Data represent mean ± SD of all 7 subjects. (B) Scatterplot comparing mean VT values from each region (excluding cerebellum) by MA1voxel method vs. 2-tissue-compartment model in 40-y-old healthy man injected with 755 MBq of 11C-NOP-1A. Simple linear regression was significant (Pearson R2 = 0.95, P < 0.0001), with linear regression line equation y = 1.05x + 0.1. Solid line represents line of best fit. Dashed lines are 95% confidence intervals. FC = frontal cortex; PA = parietal cortex; OC = occipital cortex; TC = temporal cortex; MT = medial temporal cortex; CC = cingulate cortex; CA = caudate cortex; PU = putamen; TH = thalamus; CE = cerebellum.

HHS Vulnerability Disclosure